235
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Bupropion-SR for Smoking Cessation in Early Recovery from Alcohol Dependence: A Placebo-Controlled, Double-Blind Pilot Study

, M.D., , Ph.D., , Ph.D. & , M.D.
Pages 487-490 | Published online: 29 Jul 2011

REFERENCES

  • CDC. Cigarette use among high school students – United States, 1991–2009. Morb Mortal Wkly Rep 2010; 59(26):797–801.
  • Bobo JK. Nicotine dependence and alcoholism epidemiology and treatment. J Psychoactive Drugs 1989; 21(3):323–329.
  • Joseph AM. Nicotine treatment at the drug dependency program of the Minneapolis VA Medical Center: A researcher’s perspective. J Subst Abuse Treat 1993; 10(2):147–152.
  • Hurt RD, Offord KP, Croghan IT, . Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. J Am Med Assoc 1996; 275(14):1097–1103.
  • Hays JT, Schroeder DR, Offord KP, . Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med 1999; 21(3):244–250.
  • McAfee T, France E. Sustained-release bupropion for smoking cessation. N Engl J Med 1998; 338(9):619–620.
  • Leeman RF, McKee SA, Toll BA, . Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res 2008; 10(12):1793–1809.
  • Hayford KE, Patten CA, Rummans TA, . Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 1999; 174:173–178.
  • Grant KM, Kelley SS, Smith LM, Agrawal S, Meyer JR, Romberger DJ. Bupropion and nicotine patch as smoking cessation aids in alcoholics. Alcohol 2007; 41(5):381–391.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86(9):1119–1127.
  • First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for Axis I DSM-IV Disorders, Patient Edition (SCID-II, version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute, 1994.
  • Hurt RD, Sachs DP, Glover ED, . A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337(17):1195–1202.
  • US Department of Health and Human Services. You can quit smoking. Consumer guide. 2006. Available at http://www.ahrq.gov/consumer/tobacco/quits.pdf. Last accessed on July, 2011.
  • Shiffman S. How many cigarettes did you smoke? Assessing cigarette consumption by global report, time-line follow-back, and ecological momentary assessment. Health Psychol 2009; 28(5):519–526.
  • Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol 1999; 7(4):354–361.
  • Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. Baltimore, MD: Clinical Psychometric Research, 1982.
  • Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53(3):983–997.
  • Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006; 8(6):739–749.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.